Form 4 holding
10%+ Owner
Viridian Therapeutics, Inc.\DE
- Security class
- Common Stock
- Shares / value
- 1,505,200
- Estimated value
- $31,609,200
- Report date
- 23 Sep 2021
- Price
- $21.00
- Ownership
- Direct
Frazier Life Sciences Public Fund, L.P. - 10%+ Owner at Viridian Therapeutics, Inc.\DE
Issuer-level insider activity
- Role
- 10%+ Owner
- Issuer ticker
- VRDN on Nasdaq
- Entity type
- Company
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Frazier Life Sciences Public Fund, L.P. since 05 Sep 2025
Reported holdings for Frazier Life Sciences Public Fund, L.P. in Viridian Therapeutics, Inc.\DE
Transaction history for Frazier Life Sciences Public Fund, L.P. in Viridian Therapeutics, Inc.\DE
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.